Showing results (641-650 of 664) with videos related to

Sort By:
Pageof 67
BMJ Open|June 23, 2019
'Links2HealthierBubs' cohort study: protocol for a record linkage study on the safety, uptake and effectiveness of influenza and pertussis vaccines among pregnant Australian womenMohinder Sarna, Ross Andrews, Hannah Moore, et al.
The New Phytologist|January 2, 2026
Small understory trees increase growth following sustained drought in the AmazonMateus C Silva, David C Bartholomew, André L Giles, et al.
Cancer|October 18, 2021
Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specifiedLuana G Sousa, Kaiwen Wang, Danice Torman, et al.
Annals of Neurology|August 9, 2021
Leucine-Rich Glioma-Inactivated 1 versus Contactin-Associated Protein-like 2 Antibody Neuropathic Pain: Clinical and Biological ComparisonsSudarshini Ramanathan, Mandy Tseng, Alexander J Davies, et al.
Plos One|January 24, 2024
"Putting the power back into community": A mixed methods evaluation of a chronic hepatitis B training course for the Aboriginal health workforce of Australia's Northern TerritoryKelly Hosking, Teresa De Santis, Emily Vintour-Cesar, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 2018
Bacteria and viruses in the nasopharynx immediately prior to onset of acute lower respiratory infections in Indigenous Australian childrenHeidi C Smith-Vaughan, Michael J Binks, Jemima Beissbarth, et al.
International Journal of Pediatric Otorhinolaryngology|November 11, 2023
Otitis media at 6-monthly assessments of Australian First Nations children between ages 12-36 months: Findings from two randomised controlled trials of combined pneumococcal conjugate vaccinesA J Leach, N Wilson, B Arrowsmith, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Open Forum Infectious Diseases|August 10, 2023
Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19Philip Robinson, Sima S Toussi, Sudeepta Aggarwal, et al.
Immunology and Cell Biology|September 19, 2023
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19Wuji Zhang, E Bridie Clemens, Lukasz Kedzierski, et al.
Pageof 67